Triprilimab(JS001) and Chemotherapy Combined With Local Treatment for Multiple Metastatic NPC
Status:
Not yet recruiting
Trial end date:
2023-06-15
Target enrollment:
Participant gender:
Summary
This study is a randomized, phase II, prospective, multicenter clinical trial to evaluate the
efficacy and tolerability of JS001 and chemotherapy combined with local treatment in patients
with multiple metastatic nasopharyngeal carcinoma.
Phase:
Phase 2
Details
Lead Sponsor:
Fujian Cancer Hospital
Collaborators:
Jiangxi Provincial Cancer Hospital Zhejiang Cancer Hospital